Recommend Autophagy to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts!

home subscribe search archive forthcoming

Email this page Print this page

Article Addendum

Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium

Francesco Fornai, Patrizia Longone, Michela Ferrucci, Paola Lenzi, Ciro Isidoro, Stefano Ruggieri and Antonio Paparelli

volume 4 | issue 4

16 May 2008
Pages: 527 - 530

This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

In a pilot clinical study that we recently published we found that lithium administration slows the progression of Amyotrophic Lateral Sclerosis (ALS) in human patients. This clinical study was published in addition with basic (in vitro) and pre-clinical (in vivo) data demonstrating a defect of autophagy as a final common pathway in the genesis of ALS. In fact, lithium was used as an autophagy inducer. In detailing the protective effects of lithium we found for the first time that this drug stimulates the biogenesis of mitochondria in the central nervous system and, uniquely in the spinal cord, it induces neuronogenesis and neuronal differentiation. In particular, the effects induced by lithium can be summarized as follows: (i) the removal of altered mitochondria and protein aggregates; (ii) the biogenesis of well-structured mitochondria; (iii) the suppression of glial proliferation; (iv) the differentiation of newly formed neurons in the spinal cord towards a specific phenotype.

In this addendum we focus on defective autophagy as a “leit motif” in ALS and the old and novel features of lithium which bridge autophagy activation to concomitant effects that may be useful for the treatment of a variety of neurodegenerative disorders. In particular, the biogenesis of mitochondria and the increase of calbindin D 28K-positive neurons, which are likely to support powerful neuroprotection towards autophagy failure, mitochondriopathy, and neuronal loss in the spinal cord.

Addendum to: Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, Lazzeri G, Spalloni A, Bellio N, Lenzi P, Modugno N, Siciliano G, Isidoro C, Murri L, Ruggieri S, Paparelli A. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2008; 105:2052-2057.

Authors

Francesco Fornai

University of Pisa

Patrizia Longone

IRCCS Santa Lucia Foundation

Michela Ferrucci

University of Pisa

Paola Lenzi

University of Pisa

Ciro Isidoro

University of Novara

Stefano Ruggieri

IRCCS INM Neuromed

Antonio Paparelli

University of Pisa


This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.